TR199901250T2 - Tedavi amaçli ajanlar. - Google Patents

Tedavi amaçli ajanlar.

Info

Publication number
TR199901250T2
TR199901250T2 TR1999/01250T TR9901250T TR199901250T2 TR 199901250 T2 TR199901250 T2 TR 199901250T2 TR 1999/01250 T TR1999/01250 T TR 1999/01250T TR 9901250 T TR9901250 T TR 9901250T TR 199901250 T2 TR199901250 T2 TR 199901250T2
Authority
TR
Turkey
Prior art keywords
ibuprofen
active ingredient
phospholipid material
therapeutic agents
liquid
Prior art date
Application number
TR1999/01250T
Other languages
English (en)
Inventor
Dickinson Jeffrey
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of TR199901250T2 publication Critical patent/TR199901250T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Suyla karistirildiginda 7'nin altinda pH'a sahip bir sivi karisimi açiga çikaran, 100 C'nin altinda bir erime noktasina sahip bir ibuprofen aktif bilesen meydana getiren ibuprofen ilaci da dahil olmak üzere bir ya da daha fazla ilaçtan ve ibuprofen ilaci ile iyice karistirilmis bir fosfolipid materyalinden meydana gelen bir ibuprofen kompozisyonudur. Fosfolipid materyali, bahsedilen kompozisyona suyun eklenmesi ile bahsedilen ibuprofen aktif içerikten büyük ölçüde yoksun bir sivi fazi ve temel olarak bahsedilen fosfolipid materyali ve bahsedilen ibuprofen aktif içerik de dahil olmak üzere çözülmeyen farmakolojik olarak aktif bilesenden olusan bir emulsiyon ya da dagilmadan meydana gelen bir sivi preparasyon olusturabilme yetenegine sahiptir.
TR1999/01250T 1996-12-10 1997-12-09 Tedavi amaçli ajanlar. TR199901250T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9625589.8A GB9625589D0 (en) 1996-12-10 1996-12-10 Therapeutic agents

Publications (1)

Publication Number Publication Date
TR199901250T2 true TR199901250T2 (tr) 2000-06-21

Family

ID=10804192

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01250T TR199901250T2 (tr) 1996-12-10 1997-12-09 Tedavi amaçli ajanlar.

Country Status (27)

Country Link
US (1) US6287592B1 (tr)
EP (1) EP0946156B1 (tr)
JP (1) JP2001508768A (tr)
KR (1) KR20000069418A (tr)
CN (1) CN1275910A (tr)
AR (1) AR010758A1 (tr)
AT (1) ATE213628T1 (tr)
AU (1) AU723608B2 (tr)
BG (1) BG103552A (tr)
CA (1) CA2274773C (tr)
CZ (1) CZ204599A3 (tr)
DE (1) DE69710774T2 (tr)
DK (1) DK0946156T3 (tr)
ES (1) ES2173516T3 (tr)
GB (1) GB9625589D0 (tr)
HK (1) HK1021941A1 (tr)
HU (1) HUP0003583A2 (tr)
IL (1) IL130367A0 (tr)
NO (1) NO992806L (tr)
NZ (1) NZ336079A (tr)
PL (1) PL338920A1 (tr)
PT (1) PT946156E (tr)
RU (1) RU2207851C2 (tr)
SK (1) SK76799A3 (tr)
TR (1) TR199901250T2 (tr)
WO (1) WO1998025595A2 (tr)
ZA (1) ZA9711029B (tr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
AU2002338230A1 (en) * 2001-03-26 2002-10-15 Giventis Gmbh Food item for increasing cognitive capacity
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
TWI355936B (en) * 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
WO2005051347A2 (en) * 2003-10-30 2005-06-09 Dianne Elizabeth Marshall A simple process and formulation for making taste-­ masked ibuprofen liquid preparations and similar good­-tasting preparation of other pharmaceutically active or bitter, poor tasting compounds for the production of liquid preparations
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
KR100582604B1 (ko) 2004-06-16 2006-05-23 보람제약주식회사 항산화제를 포함한 이부프로펜 및 덱시부프로펜의마이크로 에멀젼과 이를 이용한 투명 액제 및 투명연질캡슐 제제
DE102004043824A1 (de) * 2004-09-10 2006-03-16 Cognis Ip Management Gmbh Emulsionen mit ungesättigten Fettsäuren und deren Estern
US20060292225A1 (en) * 2005-06-24 2006-12-28 Felix Arthur M Water soluble analgesic formulations and methods for production
US20140072617A1 (en) * 2007-09-26 2014-03-13 Lvmh Recherche Method for preventing or slowing down the appearance of the effects of skin ageing using a tocopheryl phosphate in liposomes
US20110308985A1 (en) * 2009-02-26 2011-12-22 Gina Van Bogaert Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
GB2469849A (en) * 2009-04-29 2010-11-03 Perrigo Unit dose sachets comprising Ibuprofen
CA2752849C (en) 2009-07-24 2014-07-08 Bernd G. Seigfried Liquid compositions capable of foaming and including active agents, and methods for making or developing same
GB2477590A (en) * 2010-02-05 2011-08-10 Biocopea Ltd A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US20130309215A1 (en) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Fur Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmaceutical composition
WO2015163832A1 (en) 2014-04-25 2015-10-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. An ibuprofen and famotidine combined composition having improved stability
JP6920197B2 (ja) 2014-06-11 2021-08-18 ポビバ コーポレーションＰｏｖｉｖａ Ｃｏｒｐ． 親油性活性剤を注入された飲食料品組成物とその使用方法
ES2835720T3 (es) * 2014-06-11 2021-06-23 Poviva Corp Composiciones de alimentos y bebidas infusionadas con agentes activos lipófilos y métodos de uso de las mismas
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
CA3172889C (en) 2020-04-20 2024-05-28 John Docherty Compositions and methods for enhanced delivery of antiviral agents

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52111533A (en) 1976-03-12 1977-09-19 Kanebo Ltd Preparation of fine powder of ibuprophene
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
JPS5859912A (ja) 1981-10-06 1983-04-09 Green Cross Corp:The 鎮痛消炎物質脂肪乳剤
JPS5913720A (ja) 1982-07-15 1984-01-24 Green Cross Corp:The フルルビプロフエン脂肪乳剤
JPS60208910A (ja) 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
JPH0611697B2 (ja) 1985-02-28 1994-02-16 エスエス製薬株式会社 経口投与持続性カプセル剤
US4816247A (en) 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
US4879108A (en) * 1985-12-20 1989-11-07 Warner-Lambert Company Confectionery delivery system for antipyretics
GB8623557D0 (en) 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
GB8630273D0 (en) 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
CA1319886C (en) 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5288500A (en) * 1987-03-13 1994-02-22 Benzon Pharma A/S Oral composition containing particles comprising an active substance
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
US4975465A (en) 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
JP2844756B2 (ja) 1989-12-01 1999-01-06 日本新薬株式会社 脂肪乳剤
GB9007052D0 (en) 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
US5110606A (en) * 1990-11-13 1992-05-05 Affinity Biotech, Inc. Non-aqueous microemulsions for drug delivery
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
WO1994005260A1 (en) 1992-09-03 1994-03-17 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
GB9302720D0 (en) * 1993-02-11 1993-03-24 Scherer Ltd R P Products in capsule form for use in aqueous solution
US5785976A (en) * 1993-03-05 1998-07-28 Pharmacia & Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
CA2091152C (en) * 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
CA2120197A1 (en) 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
US5407921A (en) 1993-07-01 1995-04-18 Kao Corporation Method for suppressing bitter taste
DE4323636A1 (de) 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
ZA945944B (en) 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5672358A (en) * 1994-06-21 1997-09-30 Ascent Pharmaceuticals, Inc. Controlled release aqueous emulsion
CA2153553A1 (en) * 1994-07-13 1996-01-14 Hidekazu Suzuki Stable lipid emulsion
IT1270678B (it) 1994-10-20 1997-05-07 Bayer Ag Liposomi al chetoprofen
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
IT1276160B1 (it) 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
US5891465A (en) 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth

Also Published As

Publication number Publication date
CZ204599A3 (cs) 1999-09-15
ATE213628T1 (de) 2002-03-15
NO992806L (no) 1999-08-09
DE69710774D1 (de) 2002-04-04
CN1275910A (zh) 2000-12-06
ES2173516T3 (es) 2002-10-16
AU5760598A (en) 1998-07-03
CA2274773C (en) 2008-08-26
SK76799A3 (en) 2000-05-16
CA2274773A1 (en) 1998-06-18
WO1998025595A3 (en) 2000-05-04
RU2207851C2 (ru) 2003-07-10
PL338920A1 (en) 2000-11-20
US6287592B1 (en) 2001-09-11
EP0946156A2 (en) 1999-10-06
JP2001508768A (ja) 2001-07-03
WO1998025595A2 (en) 1998-06-18
DK0946156T3 (da) 2002-06-10
HK1021941A1 (en) 2000-07-21
EP0946156B1 (en) 2002-02-27
IL130367A0 (en) 2000-06-01
DE69710774T2 (de) 2002-10-31
PT946156E (pt) 2002-08-30
KR20000069418A (ko) 2000-11-25
NO992806D0 (no) 1999-06-09
HUP0003583A2 (hu) 2001-04-28
GB9625589D0 (en) 1997-01-29
AR010758A1 (es) 2000-07-12
AU723608B2 (en) 2000-08-31
NZ336079A (en) 2001-03-30
ZA9711029B (en) 1998-06-10
BG103552A (en) 2000-04-28

Similar Documents

Publication Publication Date Title
TR199901250T2 (tr) Tedavi amaçli ajanlar.
MY118835A (en) Sustained release compositions and the process for their preparation
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
KR930016091A (ko) 거의 수불용성인 약제의 고체 분산액을 제조하는 방법
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
TR200000517T2 (tr) Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon.
CY1109567T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δροσπιρενονη
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
PL347671A1 (en) Compounds and compositions for delivering active agents
BR0015567A (pt) Compostos de ácido fenoxicarboxìlico e composições para liberar agentes ativos
ATE260649T1 (de) Pharmazeutische formulierung und dosierform bestehend aus polysacchariden zur kontrollierten wirkstoff-freisetzung im dickdarm
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
WO1998058629A3 (en) Preparation of pharmaceutical compositions
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
PT975334E (pt) Microparticulas biodegradaveis para a libertacao sustentada de farmacos terapeuticos
SE9603480D0 (sv) Beredningsform för svårlösliga läkemedel
DE69906982D1 (de) Ibuprofen und domperidone enthaltende pharmazeutische zusammensetzungen
ES2150305T3 (es) Composicion anhidra a base de lactulosa.
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
MX9301308A (es) Composiciones mixtas de bebida de psyllium sin sabor.
BG106368A (en) Pharmaceutical composition and its preparation
DE69614508T2 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
MY118379A (en) Therapeutic agents.
EA200101157A1 (ru) 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ
DE69918124T2 (de) Zusammensetzungen und Vorrichtungen zur transdermalen Verabreichung von Fenoldopam